Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (80)
“Mini-mental state”
1975 • 82,784 citations
Clinical diagnosis of Alzheimer's disease
1984 • 27,279 citations
Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain
2002 • 15,303 citations
Neuropathological stageing of Alzheimer-related changes
1991 • 14,533 citations
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
2003 • 8,902 citations
The Clinical Dementia Rating (CDR)
1993 • 8,861 citations
What's wrong with Bonferroni adjustments
1998 • 5,540 citations
A nonparametric method for automatic correction of intensity nonuniformity in MRI data
1998 • 4,609 citations
Current Concepts in Mild Cognitive Impairment
2001 • 4,609 citations
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
2004 • 4,223 citations
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
1991 • 4,120 citations
The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods
2008 • 3,825 citations
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders
1994 • 2,484 citations
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
2007 • 1,695 citations
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
2006 • 1,661 citations
Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data
2005 • 1,225 citations
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
2005 • 1,216 citations
Imaging β-amyloid burden in aging and dementia
2007 • 1,037 citations
[ 11 C]PIB in a nondemented population
2006 • 1,030 citations
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
2008 • 1,004 citations
Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents
2003 • 953 citations
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
2008 • 929 citations
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
2008 • 903 citations
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
2000 • 898 citations
Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults
2007 • 869 citations
MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease
1992 • 848 citations
-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
2007 • 792 citations
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
2004 • 791 citations
PET imaging of amyloid deposition in patients with mild cognitive impairment
2007 • 701 citations
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
2008 • 644 citations
Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease
1999 • 631 citations
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
2004 • 617 citations
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
2006 • 605 citations
Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults.
1989 • 592 citations
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia
2002 • 574 citations
Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.
2005 • 524 citations
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
2005 • 517 citations
Amyloid, hypometabolism, and cognition in Alzheimer disease
2006 • 506 citations
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI
2005 • 482 citations
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
2007 • 478 citations
Imaging amyloid deposition in Lewy body diseases
2008 • 440 citations
PET imaging of amyloid in Alzheimer's disease
2004 • 438 citations
The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease
1999 • 427 citations
Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia
2006 • 385 citations
The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI
1997 • 380 citations
11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
2007 • 363 citations
Using Serial Registered Brain Magnetic Resonance Imaging to Measure Disease Progression in Alzheimer Disease
2000 • 353 citations
Cerebrospinal Fluid Tau and β-Amyloid
2003 • 350 citations
Hippocampal volume as an index of Alzheimer neuropathology
2002 • 343 citations
Molecular Imaging With Pittsburgh Compound B Confirmed at Autopsy
2007 • 343 citations
MRI correlates of neurofibrillary tangle pathology at autopsy
2008 • 331 citations
PET amyloid ligand [ 11 C]PIB uptake is increased in mild cognitive impairment
2007 • 320 citations
The Short Test of Mental Status
1991 • 318 citations
Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study
2006 • 315 citations
PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
2007 • 301 citations
Neuropathological basis of magnetic resonance images in aging and dementia
2007 • 295 citations
Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
2008 • 288 citations
Changes in premorbid brain volume predict Alzheimer’s disease pathology
2003 • 275 citations
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
2008 • 271 citations
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
2005 • 257 citations
Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia
2005 • 236 citations
Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease
2007 • 208 citations
Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study
2003 • 206 citations
Assessment of β-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography With Carbon 11–Labeled Pittsburgh Compound B
2008 • 205 citations
Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in Mild Cognitive Impairment
2003 • 198 citations
Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography study
2006 • 180 citations
Atrophy rates accelerate in amnestic mild cognitive impairment
2007 • 169 citations
Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage
2008 • 167 citations
Rates of cerebral atrophy differ in different degenerative pathologies
2006 • 163 citations
The Appropriateness of Analysis of Variance and Multiple-Comparison Procedures
1983 • 151 citations
Core biological marker candidates of Alzheimer?s disease ? perspectives for diagnosis, prediction of outcome and reflection of biological activity
2004 • 129 citations
Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects.
2004 • 119 citations
Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients
2003 • 113 citations
No association of CSF biomarkers with APOE 4, plaque and tangle burden in definite Alzheimer's disease
2007 • 112 citations
Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study
2008 • 103 citations
Methodological considerations for measuring rates of brain atrophy
2003 • 90 citations
Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B
2008 • 77 citations
Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern?
2008 • 67 citations
P1‐288: Automated ROI analysis of 11C Pittsburgh compound B images using structural magnetic resonance imaging atlases
2008 • 3 citations
Deleted Work
1955 • 0 citations